ATE462431T1 - Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht - Google Patents

Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht

Info

Publication number
ATE462431T1
ATE462431T1 AT05773033T AT05773033T ATE462431T1 AT E462431 T1 ATE462431 T1 AT E462431T1 AT 05773033 T AT05773033 T AT 05773033T AT 05773033 T AT05773033 T AT 05773033T AT E462431 T1 ATE462431 T1 AT E462431T1
Authority
AT
Austria
Prior art keywords
obesity
treatment
radical
furanalkylene
production
Prior art date
Application number
AT05773033T
Other languages
English (en)
Inventor
Antoine Piccirilli
Philippe Msika
Nathalie Piccardi
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0405782A external-priority patent/FR2870742B1/fr
Priority claimed from FR0502758A external-priority patent/FR2870743B1/fr
Application filed by Expanscience Lab filed Critical Expanscience Lab
Application granted granted Critical
Publication of ATE462431T1 publication Critical patent/ATE462431T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05773033T 2004-05-28 2005-05-27 Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht ATE462431T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0405782A FR2870742B1 (fr) 2004-05-28 2004-05-28 Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
FR0502758A FR2870743B1 (fr) 2005-03-21 2005-03-21 Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement de l'obesite et pour le traitement cosmetique de la surcharge ponderale
PCT/FR2005/001312 WO2005117857A1 (fr) 2004-05-28 2005-05-27 Utilisation d’alkyle furannes pour la preparation d'un medicament destine au traitement de l’obesite et pour le traitement cosmetique de la surcharge ponderale

Publications (1)

Publication Number Publication Date
ATE462431T1 true ATE462431T1 (de) 2010-04-15

Family

ID=34978848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05773033T ATE462431T1 (de) 2004-05-28 2005-05-27 Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht

Country Status (10)

Country Link
US (1) US7589121B2 (de)
EP (1) EP1750695B1 (de)
JP (2) JP4842260B2 (de)
AT (1) ATE462431T1 (de)
CA (1) CA2567479C (de)
DE (1) DE602005020274D1 (de)
ES (1) ES2340510T3 (de)
MX (1) MXPA06013885A (de)
PL (1) PL1750695T3 (de)
WO (1) WO2005117857A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1750695T3 (pl) * 2004-05-28 2010-08-31 Expanscience Lab Zastosowanie alkilofuranów do wytwarzania leku przeznaczonego do leczenia otyłości i do kosmetycznego leczenia nadwagi ciała
FR2870742B1 (fr) * 2004-05-28 2008-03-14 Expanscience Laboratoires Sa Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
FR2889956B1 (fr) * 2005-08-30 2012-04-20 Expanscience Lab Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
US20110217251A1 (en) * 2008-09-08 2011-09-08 Shai Meretzki Therapeutic compositions comprising polyhydroxyltate fatty alcohol derivatives and uses thereof
EP2340089A2 (de) * 2008-09-08 2011-07-06 Polyol Biotech Ltd. Kosmetische zusammensetzungen mit polyhydroxylierten fettalkoholen und ihre derivate und anwendungen
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
FR2949044B1 (fr) * 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
JP5818300B2 (ja) * 2010-12-27 2015-11-18 雪印メグミルク株式会社 ミルクセラミド含有食品及びその製造方法
WO2014160940A2 (en) 2013-03-29 2014-10-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
EP3119387A4 (de) * 2014-03-20 2017-12-06 Eberting, Cheryl Lee Zusammensetzungen zur behandlung von dermatologischen erkrankungen und störungen
WO2017189865A1 (en) 2016-04-27 2017-11-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis
MX2022002947A (es) 2019-09-12 2022-06-14 Sp Nutraceuticals Inc Avocatina b para el tratamiento de enfermedades y afecciones.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127592A (en) 1977-03-31 1978-11-28 Polak's Frutal Works, B.V. Process of the preparation of hydroxyfurenones
CA1169431A (en) 1980-08-27 1984-06-19 Roger A. Parker Acylated furanyl and thienyl acrylic acids
DE3372252D1 (en) 1982-10-29 1987-07-30 Plessey Overseas Conductive gaskets
FR2678632B1 (fr) 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2678614A1 (fr) 1991-07-03 1993-01-08 Pharmascience Lab Compose presentant une activite en tant qu'inhibiteur de la collagenase et medicament le contenant.
US5468490A (en) * 1993-10-25 1995-11-21 Conkle & Olesten Lipidic furans useful for skin therapeutics
JPH08332061A (ja) * 1995-06-07 1996-12-17 Sanki Shoji Kk アボカド葉茶とその飲料及び抽出液乾固物
WO1998000389A1 (en) 1996-07-02 1998-01-08 Sang Sup Jew 2-hydroxypropionic acid derivative and its manufacturing method
JP4047441B2 (ja) * 1998-03-05 2008-02-13 株式会社資生堂 脂質分解促進剤および痩身用皮膚外用剤
JP2000144170A (ja) * 1998-09-01 2000-05-26 Janifu Tekku:Kk 抗肥満及び内臓蓄積脂肪低減化機能を有する物質、及びその用途
DE19901502C1 (de) 1999-01-11 2000-09-21 Michael Schneider Anticellulitiszusammensetzung und ihre Verwendung
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
JP4693964B2 (ja) * 2000-08-07 2011-06-01 カゴメ株式会社 新規摂食抑制剤
JP2002212177A (ja) * 2000-11-14 2002-07-31 Takeda Chem Ind Ltd 脂質代謝改善剤
KR100637564B1 (ko) * 2001-01-26 2006-10-20 추가이 세이야쿠 가부시키가이샤 대사 조절자로서 유용한 말로닐-코에이 데카르복실라제억제제
US20030120073A1 (en) * 2001-04-25 2003-06-26 Seto Christopher T. Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
JP2005232005A (ja) 2001-07-02 2005-09-02 Maruha Corp 新規脂肪族化合物、合成方法、利用方法
WO2003007888A2 (en) 2001-07-20 2003-01-30 Adipogenix, Inc. Fat accumulation-modulating compounds
US20040033506A1 (en) 2001-11-30 2004-02-19 Dennis Farrelly Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof
FR2841470B1 (fr) * 2002-06-27 2006-01-13 Pharmascience Lab Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
WO2004016106A1 (fr) 2002-07-29 2004-02-26 Laboratoires Expanscience Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques
US6793946B2 (en) * 2002-07-31 2004-09-21 Access Business Group International Llc. Composition and method for lowering cholesterol
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
US20050048144A1 (en) 2003-08-29 2005-03-03 Xiao-Qing Han Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it
PL1750695T3 (pl) * 2004-05-28 2010-08-31 Expanscience Lab Zastosowanie alkilofuranów do wytwarzania leku przeznaczonego do leczenia otyłości i do kosmetycznego leczenia nadwagi ciała

Also Published As

Publication number Publication date
US20070238777A1 (en) 2007-10-11
CA2567479A1 (fr) 2005-12-15
MXPA06013885A (es) 2007-01-26
PL1750695T3 (pl) 2010-08-31
US7589121B2 (en) 2009-09-15
JP2008501004A (ja) 2008-01-17
ES2340510T3 (es) 2010-06-04
EP1750695A1 (de) 2007-02-14
EP1750695B1 (de) 2010-03-31
WO2005117857A1 (fr) 2005-12-15
HK1100279A1 (zh) 2007-09-14
JP2012006924A (ja) 2012-01-12
JP4842260B2 (ja) 2011-12-21
CA2567479C (fr) 2012-09-11
DE602005020274D1 (de) 2010-05-12
JP5405528B2 (ja) 2014-02-05

Similar Documents

Publication Publication Date Title
ATE462431T1 (de) Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht
DE602004024880D1 (de) Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
BR0014649A (pt) Utilização de um produto, medicamento, composto e composição farmacêutica
EP4393490A4 (de) Verwendung eines ezh2-hemmers bei der herstellung eines arzneimittels zur behandlung von t-zell-lymphom
ATE353646T1 (de) Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
DE502005002356D1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DK1268416T3 (da) 2-alkyliden-19-nor-vitamin-D-forbindelser og deres terapeutiske anvendelser
NO20052993L (no) 4,5-diaryltiazolderivater som CB-1 ligander.
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
NO20053748L (no) Pyrrolopyridazinderivater.
DE69432973D1 (de) Verwendung von thiazolidindionen zur behandlung von atherosklerose und essstörungen
ATE524181T1 (de) Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
ATE267597T1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
HUP9904210A2 (hu) Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények
DE50007381D1 (de) Verwendung von polyzyklischen thiazol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
CA2708538A1 (en) Topical compositions containing desthiobiotin and its derivatives and a method of treating skin
DE50010285D1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur behandlung von fettstoffwechselstörungen, obesitas und typ ii diabetes
DE50014850D1 (de) Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
ATE321552T1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
MXPA05004845A (es) N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia.
ATE232097T1 (de) Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen
DE602005027563D1 (de) Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis
HUP0302408A2 (hu) Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
ATE492285T1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
NO330964B1 (no) Kolkisosidanaloger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties